Should You Avoid Bankrate Inc (RATE)?

Because Bankrate Inc (NYSE:RATE) has weathered falling interest from the entirety of the hedge funds we track, logic holds that there is a sect of money managers who sold off their entire stakes last quarter. At the top of the heap, Matthew Tewksbury’s Stevens Capital Management sold off the largest stake of the 700 funds followed by Insider Monkey, comprising an estimated $0.2 million in stock. Matthew Hulsizer’s fund, PEAK6 Capital Management, also said goodbye to its stock, about $0.1 million worth.

Let’s now take a look at hedge fund activity in other stocks – not necessarily in the same industry as Bankrate Inc (NYSE:RATE) but similarly valued. We will take a look at ANI Pharmaceuticals Inc (NASDAQ:ANIP), Essendant Inc (NASDAQ:ESND), Hersha Hospitality Trust (NYSE:HT), and GasLog Partners LP (NYSE:GLOP). This group of stocks’ market values are similar to RATE’s market value.

As you can see these stocks had an average of 10 funds with bullish positions and the average amount invested in these stocks was $44 million, compared to $59 million in RATE’s case. ANI Pharmaceuticals Inc (NASDAQ:ANIP) is the most popular stock in this table. On the other hand GasLog Partners LP (NYSE:GLOP) is the least popular one with only three funds holding shares. Compared to these stocks Bankrate Inc (NYSE:RATE) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None